Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-509-8 | CAS number: 107-66-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Dibutyl hydrogen phosphate was investigated in the Ames test. No evidence of mutagenic activity of dibutyl hydrogen phosphate was seen (with and without mutagenic activation). Additionally, dibutyl hydrogen phosphate was evaluated negative in a cytogenetic assay and also in a CHO/HGPRT test, also with and without metabolic activation.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study without detailed documentation
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Principles of method if other than guideline:
- Ames test with S.typhimurium TA 100, TA 1535, TA 98, TA 1537, E.coli WP2 uvrA; plate incorporation assay
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S-9 mix, induced with phenobarbital and 5.6-benzoflavone
- Test concentrations with justification for top dose:
- 0, 4.882, 9.755, 19.53, 39.06, 78.12, 156.2 µg/plate
- Vehicle / solvent:
- acetone
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- not specified
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- other: -S9, AF-2 (TA100, WP2, TA98), sodium azide (TA 1535) and9-aminoacridine (TA1537); +S9, 9-aminoanthracen (all strains)
- Details on test system and experimental conditions:
- Ames test
- Key result
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- toxicity was observed at 156.2 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- see result Tables 1 and 2 - attached
- Conclusions:
- Interpretation of results: negative
- Executive summary:
An Ames test with S.typhimurium strains TA 100, TA 1535, TA 98, TA 1537, and E.coli WP2 uvrA was conducted with dibutyl hydrogen phosphate according the guidelines for screening mutagenicity testing of chemicals (Japan).
Dibutyl hydrogen phosphate was tested in concentrations of 4.882 to 156.2 µg/plate. Toxicity was observed at 156.2 µg/plate, with and without metabolic activation. The test results were negative in all strains, with and without metabolic activation.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: scientifically acceptable and sufficiently documented
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Principles of method if other than guideline:
- Mutagenicity of dibutyl hydrogen phosphate was investigated in a chromosomal aberration test with Chinese hamster CHL/IU cells.
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- mammalian cell line, other: Chinese hamster CHL/IU cells
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S-9 mix from rat liver, induced with phenobarbital and 5,6-benzoflavone
- Test concentrations with justification for top dose:
- without S9 mix (continuous treatment for 24 and 48 hours): 0, 0.06, 0.12, 0.24 mg/mL
without S9 mix (short-term treatment for 6 hours): 0, 0.10, 0.21, 0.41 mg/mL
plus S9 mix (short-term treatment for 6 hours): 0, 0.14, 0.27, 0.54 mg/mL
Justification of dose based on cell growth experiments. - Vehicle / solvent:
- acetone
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Details on test system and experimental conditions:
- plates per test: 2
No. of cells analysed per culture: 200 - Evaluation criteria:
- Number of structural aberrations and number of cells with aberrations; polyploidy
- Statistics:
- yes
- Key result
- Species / strain:
- Chinese hamster lung (CHL/IU)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- -S9 (continuous treatment): > 0.24 mg/ml; -S9 (short-term treatment): > 0.41 mg/ml; +S9 (short-term treatment): > 0.54 mg/ml
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- see tables 1 and 2 attached
- Conclusions:
- Interpretation of results: negative
- Executive summary:
The mutagenicity of dibutyl hydrogen phosphate was investigated in a chromosomal aberration test with Chinese hamster CHL/IU cells, following the Japanese Guidelines for Mutagenicity Testing of Chemicals. The cell cultures were treated for 24 and 48 hours without S9 mix (continuous treatment) and for 6 hours with and without S9 mix. Concentrations were based on cytotoxicity, including test item concentrations that induced 50% cell growth. Neither clastogenic effects (structural and numerical chromosomal aberrations) nor polyploidy became obvious in these experiments. Dibutyl hydrogen phosphate can thus be considered as negative in the chromosomal aberration test.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- 1998
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- HPRT locus
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Additional strain / cell type characteristics:
- other: the cells have a stable karyothype with a modal chromosome number of 22
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- exposure S9
period mix
concentrations in µg/mL
Experiment I
4 hours - 137.5 275.0 550.0 1100.0 2200.0
4 hours + 137.5 275.0 550.0 1100.0 2200.0
Experiment II
24 hours - 137.5 275.0 550.0 1100.0 2200.0
4 hours + 137.5 275.0 550.0 1100.0 2200.0 - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- Vehicle used: Concurrent solvent controls (deionised water (local tap water, deionised at Harlan CCR)) were performed.
Osmolarity and pH value:
The osmolarity and pH-value were determined in the solvent control and in the maximum concentration of the pre-experiment without metabolic activation without effects.
Culture Medium
For seeding and treatment of the cell cultures the complete culture medium was MEM (minimal essential medium) containing Hank’s salts, neomycin (5 µg/mL) and amphotericin B (1 %). For the selection of mutant cells the complete medium was supplemented with 11 µg/mL 6-thioguanine. All cultures were incubated at 37 °C in a humidified atmosphere with 1.5 % CO2 (98.5 % air).
Metabolic activation system
Phenobarbital/beta-naphthoflavone induced rat liver S9
Seeding
Two to three days after sub-cultivation stock cultures were trypsinized at 37 °C for 5 minutes. Then the enzymatic digestion was stopped by adding complete culture medium with 10 % FBS and a single cell suspension was prepared. The trypsin concentration for all sub-culturing steps was 0.2 % in PBS.
The PBS is composed as follows (per litre): NaCl 8000 mg, KCl 200 mg, KH2PO4 200 mg, Na2HPO4 150 mg.
Prior to the trypsin treatment the cells were rinsed with Ca-Mg-free salt solution (PBS) containing 200 mg/l EDTA (ethylene diamine tetraacetic acid). Approximately 1.5×10E6 (single culture) and 5×10E2 cells (in duplicate) were seeded in plastic culture flasks. The cells were grown for 24 hours prior to treatment.
Pre-test on toxicity
A pre-test was performed in order to determine the concentration range for the mutagenicity experiments. The general culture conditions and experimental conditions in this pre-test were the same as described for the mutagenicity experiment below. In this pre-test the colony forming ability of approximately 500 single cells (duplicate cultures per concentration level) after treatment with the test item was observed and compared to the controls. Toxicity of the test item is indicated by a reduction of the cloning efficiency (CE).
Treatment
After 24 hours the medium was replaced with serum-free medium containing the test item, either without S9 mix or with 50 µl/mL S9 mix. Concurrent solvent and positive controls were treated in parallel. After 4 hours this medium was replaced with complete medium following two washing steps with "saline G". In the second experiment the cells were exposed to the test item for 24 hours in complete medium, supplemented with 10 % FBS, in the absence of metabolic activation.
The "saline G" solution had the following constituents (per litre): NaCl 8000 mg, KCl 400 mg, Glucose 1100 mg, Na2HPO4×2H2O 192 mg, KH2PO4 150 mg. The pH was adjusted to 7.2.
The colonies used to determine the cloning efficiency (survival) were fixed and stained approx. 7 days after treatment as described below.
Three or four days after treatment 1.5×10E6 cells per experimental point were subcultivated in 175 cm² flasks containing 30 mL medium. Following the expression time of 7 days five 80 cm² cell culture flasks were seeded with about 3 - 5×10E5 cells each in medium containing 6-TG. Two additional 25 cm² flasks were seeded with approx. 500 cells each in non-selective medium to determine the viability.
The cultures were incubated at 37 °C in a humidified atmosphere with 1.5 % CO2 for about 8 days. The colonies were stained with 10 % methylene blue in 0.01 % KOH solution.
The stained colonies with more than 50 cells were counted. In doubt the colony size was checked with a preparation microscope.
Data Recording
The data generated were recorded in the raw data.
Acceptability of the Assay
The gene mutation assay is considered acceptable if it meets the following criteria:
- the numbers of mutant colonies per 10E6 cells found in the solvent controls fall within the laboratory historical control data range
- the positive control substances should produce a significant increase in mutant colony frequencies.
- the cloning efficiency II (absolute value) of the solvent controls must exceed 50 % - Evaluation criteria:
- A test item is classified as positive if it induces either a concentration-related increase of the mutant frequency or a reproducible and positive response at one of the test points.
A test item producing neither a concentration-related increase of the mutant frequency nor a reproducible positive response at any of the test points is considered non-mutagenic in this system.
A positive response is described as follows:
A test item is classified as mutagenic if it reproducibly induces a mutation frequency that is three times above the spontaneous mutation frequency at least at one of the concentrations in the experiment.
The test item is classified as mutagenic if there is a reproducible concentration-related increase of the mutation frequency. Such evaluation may be considered also in the case that a threefold increase of the mutant frequency is not observed.
However, in a case by case evaluation this decision depends on the level of the corresponding solvent control data. If there is by chance a low spontaneous mutation rate within the laboratory´s historical control data range, a concentration-related increase of
the mutations within this range has to be discussed. The variability of the mutation rates of solvent controls within all experiments of this study was also taken into consideration. - Statistics:
- A linear regression (least squares) was performed to assess a possible dose dependent increase of mutant frequencies. The number of mutant colonies obtained for the groups treated with the test item were compared to the solvent control groups. A trend is judged as significant whenever the p-value (probability value) is below 0.05.
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: Relevant cytotoxic effects were noted at the maximum concentration of the first experiment without metabolic activation. No relevant cytotoxic effects occurred in any other experimental part of this study
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- No precipitation of the test item was observed up to the maximum concentration of all experiments.
Relevant cytotoxic effects indicated by a relative cloning efficiency I and/or relative cell density below 50% in both parallel cultures were noted at the maximum concentration of the first experiment without metabolic activation. No relevant cytotoxic effects occurred in any other experimental part of this study.
No relevant and reproducible increase in mutant colony numbers/106 cells was observed in the main experiments up to the maximum concentration. The mutant frequency did not exceed the historical range of solvent controls. The induction factor exceeded the threshold of three times the corresponding solvent control in the first culture of the first experiment without metabolic activation at 137.5 μg/mL. This increase however, was judged as biologically irrelevant since all absolute values of the mutation frequency remained within the range of historical solvent controls. Furthermore, the increase was not reproduced in the parallel culture performed under identical experimental conditions and was not dose dependent as indicated by the lacking statistical significance.
A linear regression analysis (least squares) was performed to assess a possible dose dependent increase of mutant frequencies. A single dose dependent trend of the mutation frequency indicated by a probability value of <0.05 was determined in the second culture of the first experiment without metabolic activation. This trend however, was judged as irrelevant as it actually was reciprocal, going down versus increasing concentrations.
In both experiments of this study (with and without S9 mix) the range of the solvent controls was from 8.9 up to 32.9 mutants per 10 E6 cells; the range of the groups treated with the test item was from 0.0 up to 31.3 mutants per 10 E6 cells.
EMS (150 μg/mL) and DMBA (1.1 μg/mL) were used as positive controls and showed a distinct increase in induced mutant colonies.
see attached result tables - Conclusions:
- Interpretation of results: negative
- Executive summary:
A HPRT test was performed according to OECD TG 476 to investigate the potential of dibutyl hydrogen phosphate to induce gene mutations at the HPRT locus in V79 cells of the Chinese hamster. The assay was performed in two independent experiments, using two parallel cultures each. The first main experiment was performed with and without liver microsomal activation and a treatment period of 4 hours. The second experiment was performed with a treatment time of 4 hours with and 24 hours without metabolic activation. The highest concentration of 2200 µg/mL was equal to approximately 10 mM. No substantial and reproducible dose dependent increase of the mutation frequency was observed in both main experiments. Appropriate reference mutagens, used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test system and the activity of the metabolic activation system.
In conclusion it can be stated that under the experimental conditions reported the test item did not induce gene mutations at the HPRT locus in V79 cells. Therefore, dibutylphosphate was negative in this HPRT assay.
Referenceopen allclose all
Dibutyl hydrogen phosphate was negative in Salmonella typhimurium TA100, TA98, TA1535, TA1537 and Echerichia coli WP2 uvrA with and without metabolic activation.
Neither structural nor numerical chromosomal aberrations were induced in CHL/IU cells up to the concentration inducing 50% cell growth, in the presence or absence of an exogenous metabolic activation system.
No substantial and reproducible dose dependent increase of the mutation frequency was observed in both main experiments (see attached result tables).
Appropriate reference mutagens, used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test system and the activity of the metabolic activation system.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
In an in-vivo micronucleus assay in mice no indication for a mutagenic effect was found.
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1999
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5395 (In Vivo Mammalian Cytogenetics Tests: Erythrocyte Micronucleus Assay)
- Version / remarks:
- 1998
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 1997
- Principles of method if other than guideline:
- A micronucleus test was carried out with dibutyl hydrogen phosphate. The test compound was emulsified in deionized water and was given twice at an interval of 24 hours as oral doses of 100, 300 and 1000 mg/kg bw to male and female mice. According to the test procedure the animals were killed 24 hours after administration.
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann GmbH
- Age at study initiation: approx. 7 weeks
- Weight at study initiation: males: 33.3 g; females: 27.5g
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +- 3
- Humidity (%): 50 +-20
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: 1999 - Route of administration:
- oral: gavage
- Vehicle:
- deionized water; stability and homogeneity in the vehicle confirmed over 4 hours
- Details on exposure:
- Preliminary experiment:
first dose: 2000 mg/kg bw dibutyl phosphate (3 males and 3 females) - no clinical signs, no mortality
second dose: 1500 mg/kg bw dibutyl phosphate (3 males and 3 females) - 1 out of 3 males and 2 out of 3 females died or were sacrificed for animal welfare reasons
third dose: 1200 mg/kg bw dibutyl phosphate (3 males and 3 females) - 2 out of 3 males and 1 out of 3 females died; motor activity decreased, squatting posture, palpebral fissure narrow, coat bristling
fourth dose: 1000 mg/kg bw dibutyl phosphate (3 males and 3 females) - 0 out of 3 males and 1 out of 3 females died; motor activity decreased
Conclusion: 1000 mg/kg bw twice was used as hightest dose for the main study - Duration of treatment / exposure:
- Animals were sacrificed 24 hours after the last administration of the test substance.
- Frequency of treatment:
- Twice at an interval of 24 hours.
- Post exposure period:
- 24 hours
- Dose / conc.:
- 100 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 300 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 1 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 5 males and 5 females per dose
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide distilled in water
- Route of administration: oral gavage
- Doses / concentrations: 50 mg/kg bw - Tissues and cell types examined:
- Mouse bone marrow erythrocytes.
- Details of tissue and slide preparation:
- Animals were killed by carbon dioxide asphyxiation 24 hours after dosing. For each animal, about 3 ml fetal bovine serum was poured into a centrifuge tube. Both femora were removed and the bones freed of muscle tissue. The proximal ends of the femora were opened and the bone marrow flushed into the centrifuge tube. A suspension was formed. The mixture was then centrifuged for 5 minutes at approx. 1200 rpm, after which almost all the supernatant was discarded. One drop of the thoroughly mixed sediment was smeared onto a cleaned slide, identified by project code and animal number and air-dried for about 12 hours.
- Evaluation criteria:
- 2000 polychromatic erythrocytes were counted for each animal. The number of cells with micronuclei was recorded, not the number of individual micronuclei. In addition, the ratio of polychromatic erythrocytes to 200 total erythrocy1es was determined. Main parameter for the statistical analysis, i.e. validity assessment of the study and mutagenicity of the test substance, was the proportion of polychromatic erythrocytes with micronuclei out of the 2000 counted erythrocytes.
Criteria for a positive response
Both biological and statistical significances were considered tagether for evaluation purposes. A substance is considered as positive if there is a significant dose-related increase in the number of micronucleated polychromatic erythrocy1es compared with the concurrent negative control group. A test substance producing no significant doserelated increase in the number of micronucleated polychromatic erythrocytes is considered non-mutagenic in this system. - Statistics:
- A one-sided Wilcoxon-Test was evaluated to check the validity of the study. The study was considered as valid in case the proportion of polychromatic erythrocytes with micronuclei in the positive control was significantly higher than in the negative control (p=0.05).
If the validity of the study had been shown the following sequential test procedure for the examination of the mutagenicity was applied: Based on a monotone-dose relationship one-sided Wilcoxon tests were performed starting with the highest dose group. These tests were performed with a multiple level of significance of 5%. - Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- determined in a preliminary dose finding study
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- Interpretation of results: negative
- Executive summary:
The micronucleus test was carried out with dibutyl hydrogen phosphate following OECD TG 474. The test compound was emulsified in deionized water and was given twice at an interval of 24 hours as oral doses of 100, 300 and 1000 mg per kg body weight to male and female mice, based on the results of previous dose range finding assays. According to the test procedure the animals were killed 24 hours after administration.
Cyclophosphamide was used as positive control substance and was administered once orally at a dose of 50 mg per kg body weight.
Oral administration of 1000 mg Dibutylphosphorsäure per kg body weight resulted in the death of 2 out of 5 females treated. These animals were replaced and survived after treatment. The following clinical sign was observed: motor activity decreased.The number of polychromatic erythrocytes containing micronuclei was not increased. The ratio of polychromatic erythrocytes to total erythrocytes in both male and female animals remained unaffected by the treatment with dibutyl hydrogen phosphate and was not less than 20% of the control values.
Cyclophosphamide induced a marked statistically significant increase in the number of polychromatic cells with micronuclei, indicating the sensitivity of the test system. The ratio of polychromatic erythrocytes to total erythrocytes was not changed to a significant extent.
Under the conditions of the present study the results indicate that di-n-butylphosphate is negative in the micronucleus test.
Reference
Oral administration of 1000 mg Dibutylphosphorsäure per kg body weight resulted in the death of two female out of 5 animals treated. These animals were replaced and survived after treatment. The following clinical sign was observed: motor activity decreased.
The dissection of the two female animals which died within 24 hours after the first
application revealed the following macroscopic finding: Intestinal tract filled with orange colored spume. The dissection of all other animals revealed no test substance related macroscopic findings.
The bone marrow smears were examined for the occurrence of micronuclei in red blood cells. The summarized results and individual data of all animals in all treatment groups are presented in the attached tables.
The incidence of micronucleated polychromatic erythrocytes in the dose groups of
Dibutylphosphorsäure was within the normal range of the negative control groups.
No statistically significant increase of micronucleated polychromatic erythrocytes was observed. The ratio of polychromatic erythrocytes to total erythrocytes remained essentially unaffected by the test compound and was not less than 20% of the control values.
Cyclophosphamide induced a marked and statistically significant increase
in the number of polychromatic erythrocytes with micronuclei, thus indicating the
sensitivity of the test system.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
An Ames test with S.typhimurium strains TA 100, TA 1535, TA 98, TA 1537, and E.coli WP2 uvrA was conducted with dibutyl hydrogen phosphate according the guidelines for screening mutagenicity testing of chemicals (Japan). Dibutyl hydrogen phosphate was tested in concentrations of 4.882 to 156.2 µg/plate. Toxicity was observed at 156.2 µg/plate, with and without metabolic activation. The test results were negative in all strains, with and without metabolic activation.
The mutagenicity of dibutyl hydrogen phosphate was investigated in a chromosomal aberration test with Chinese hamster CHL/IU cells, following the Japanese Guidelines for Mutagenicity Testing of Chemicals. The cell cultures were treated for 24 and 48 hours without S9 mix (continuous treatment) and for 6 hours with and without S9 mix. Concentrations were based on cytotoxicity, including test item concentrations that induced 50% cell growth. Neither clastogenic effects (structural and numerical chromosomal aberrations) nor polyploidy became obvious in these experiments. Dibutyl hydrogen phosphate can thus be considered as negative in the chromosomal aberration test.
A HPRT test was performed according to OECD TG 476 to investigate the potential of dibutyl hydrogen phosphate to induce gene mutations at the HPRT locus in V79 cells of the Chinese hamster. The assay was performed in two independent experiments, using two parallel cultures each. The first main experiment was performed with and without liver microsomal activation and a treatment period of 4 hours. The second experiment was performed with a treatment time of 4 hours with and 24 hours without metabolic activation. The highest concentration of 2200 µg/mL was equal to approximately 10 mM. No substantial and reproducible dose dependent increase of the mutation frequency was observed in both main experiments. Appropriate reference mutagens, used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test system and the activity of the metabolic activation system. In conclusion it can be stated that under the experimental conditions reported the test item did not induce gene mutations at the HPRT locus in V79 cells. Therefore, dibutyl hydrogen phosphate was negative in this HPRT assay.
The mouse micronucleus test was carried out with dibutyl hydrogen phosphate following OECD TG 474. The test compound was emulsified in deionized water and was given twice at an interval of 24 hours as oral doses of 100, 300 and 1000 mg per kg body weight to male and female mice, based on the results of previous dose range finding assays. According to the test procedure the animals were killed 24 hours after administration.
Cyclophosphamide was used as positive control substance and was administered once orally at a dose of 50 mg per kg body weight.
Oral administration of 1000 mg dibutyl hydrogen phosphate per kg body weight resulted in the death of 2 out of 5 females treated. These animals were replaced and survived after treatment. The following clinical sign was observed: motor activity decreased. The number of polychromatic erythrocytes containing micronuclei was not increased. The ratio of polychromatic erythrocytes to total erythrocytes in both male and female animals remained unaffected by the treatment with dibutyl hydrogen phosphate and was not less than 20% of the control values.
Cyclophosphamide induced a marked statistically significant increase in the number of polychromatic cells with micronuclei, indicating the sensitivity of the test system. The ratio of polychromatic erythrocytes to total erythrocytes was not changed to a significant extent. Under the conditions of the present study the results indicate that dibutyl hydrogen phosphate is negative in the micronucleus test.
In all in vitro genetic toxicity assays (Ames test, cytogenetic test, CHO/HGPRT test) and the in vivo micronucleus test dibutyl hydrogen phosphate was negative.
Justification for classification or non-classification
Dibutyl hydrogen phosphate was negative in vitro and in vivo. According to CLP classification criteria (Regulation (EC) No 1272/2008) a classification is not justified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.